The Longitude Prize aims to tackle growing levels of antimicrobial resistance, but what exactly are we up against?
The global problem of antibiotic resistance is fast becoming one of the major scientific issues of modern times. The development of new antibiotics is slow and difficult work but bacterial resistance is decreasing our arsenal of existing drugs posing a catastrophic threat as ordinary infections become untreatable.
Preventative action is needed to help reduce resistance. The Longitude Prize aims to improve our ability to target infections more precisely by encouraging the development of new tools.
The bacteria listed below cover a range of diseases and levels of resistance. All of them present a threat to humans in some way or another. Some, like Tuberculosis for example, are already a huge challenge to overcome in their own right and will only become harder to control as their resistance to antibiotics grows.
Click on the individual bacteria to find out more or browse the guide to the ten most dangerous antibiotic-resistant bacteria on the Nesta website.
- Staphylococcus aureus (MRSA)
- Burkholderia cepacia
- Pseudomonas aeruginosa
- Clostridium difficile
- Klebsiella pneumoniae
- Escherichia coli (E.coli)
- Acinetobacter baumannii
- Mycobacterium tuberculosis
- Neisseria gonorrhoeae
- Streptococcus pyogenes
Discover more about the challenge of tackling resistance.
Enter the Prize
The Longitude Prize is a £10m prize fund that will reward a competitor that can develop a point–of–care diagnostic test that will conserve antibiotics for future generations and revolutionise the delivery of global healthcare. The test must be accurate, rapid, affordable and easy to use anywhere in the world.